출판：Inkwood Research（잉크우드 리서치） 출판년월：2022년03월
GLOBAL GENETIC TESTING MARKET FORECAST 2022-2030
전 세계 유전자 검사 시장은 2022-2030년 예측 기간 동안 10.25%의 CAGR을 예상할 것으로 예상
| 페이지수 | 240 |
| 가격 | |
| 싱글 사용자 라이센스 | USD 2,500 |
| 다중 사용자 라이센스 | USD 3,000 |
| 엔터프라이즈 라이센스 | USD 4,500 |
| 구성 | 영문조사보고서 |
KEY FINDINGS
The global genetic testing market is set to project a CAGR of 10.25% during the forecast period, 2022-2030. The growing direct-to-consumer genetic testing, biotechnology advancements, and increasing prenatal testing drive market growth.
전 세계 유전자 검사 시장은 2022-2030년 예측 기간 동안 10.25%의 CAGR을 예상할 것으로 예상됩니다. 증가하는 소비자 직접 유전자 검사, 생명 공학 발전 및 증가하는 산전 검사가 시장 성장을 주도합니다.
MARKET INSIGHTS
Genetic testing is used to determine a person’s vulnerability to developing specific diseases or disorders. The major types of genetic testing include diagnostic testing, newborn screening, and prenatal testing.
Prenatal genetic testing comprises 31.2% of all genetic tests. Genetic testing can detect pre-birth diseases. It can help detect certain types of abnormalities in a baby’s genes during pregnancy. Among these, Trisomy 18 and down syndrome are often screened for as part of prenatal genetic testing. Conventionally, it is conducted through invasive testing like amniocentesis. Also, tests like cell-free DNA testing evaluate a baby’s DNA through a blood test conducted on the mother. The growth of parental genetic testing is attributed to the fears associated with developing genetic disorders in children. Such aspects contribute to the global genetic testing market growth. However, government regulations and high treatment costs hinder the market growth.
REGIONAL INSIGHTS
The global genetic testing market growth assessment includes the geographical analysis of North America, Europe, Asia-Pacific, and Rest of World. North America is the dominating region in the global market in terms of market share. This is accredited to the well-developed healthcare infrastructure and economic growth.
COMPETITIVE INSIGHTS
With a small number of companies manufacturing complex devices, the market rivalry is intense among companies to sell products. Bio-Rad Laboratories, Abbott Laboratories, CSL Limited, BGI Group, etc., are among the leading market players.
Our report offerings include:
• Explore key findings of the overall market
• Strategic breakdown of market dynamics (Drivers, Restraints, Opportunities, Challenges)
• Market forecasts for a minimum of 9 years, along with 3 years of historical data for all segments, sub-segments, and regions
• Market Segmentation cater to a thorough assessment of key segments with their market estimations
• Geographical Analysis: Assessments of the mentioned regions and country-level segments with their market share
• Key analytics: Porter’s Five Forces Analysis, Vendor Landscape, Opportunity Matrix, Key Buying Criteria, etc.
• Competitive landscape is the theoretical explanation of the key companies based on factors, market share, etc.
• Company profiling: A detailed company overview, product/services offered, SCOT analysis, and recent strategic developments
관련 시장 조사 보고서
Inkwood Research에서는 아래의 지역/국가별 시장조사보고서도 출판되어 있습니다.각 보고서의 상세 설명에 대한 문의도 받고 있습니다。
- ASIA-PACIFIC GENETIC TESTING MARKET FORECAST 2022-2030
아시아 태평양 지역의 유전자 검사 시장 예측 2022-2030 - EUROPE GENETIC TESTING MARKET FORECAST 2022-2030
유럽 유전자 검사 시장 예측 2022-2030 - NORTH AMERICA GENETIC TESTING MARKET FORECAST 2022-2030
북미 유전자 검사 시장 예측 2022-2030 - UNITED STATES GENETIC TESTING MARKET FORECAST 2022-2028
미국의 유전자 검사 시장 예측 2022-2028
목차
- RESEARCH SCOPE & METHODOLOGY
- STUDY OBJECTIVES
- SCOPE OF STUDY
- METHODOLOGY
- ASSUMPTIONS & LIMITATIONS
- EXECUTIVE SUMMARY
- MARKET SIZE & ESTIMATES
- MARKET OVERVIEW
- MARKET DYNAMICS
- KEY DRIVERS
- ADVANCEMENTS IN BIOTECHNOLOGY
- GROWTH IN PRENATAL TESTING
- RISE IN DIRECT-TO-CONSUMER GENETIC TESTING
- GENETIC TESTING HELPS IN DETERMINING MEDICATION DOSAGE
- KEY RESTRAINTS
- EXPENSIVE COST OF TREATMENT
- GOVERNMENT REGULATION AND LEGISLATION
- KEY DRIVERS
- KEY ANALYTICS
- IMPACT OF COVID-19 ON GENETIC TESTING MARKET
- KEY MARKET TRENDS
- PORTER’S FIVE FORCES ANALYSIS
- BUYERS POWER
- SUPPLIERS POWER
- SUBSTITUTION
- NEW ENTRANTS
- INDUSTRY RIVALRY
- OPPORTUNITY MATRIX
- VENDOR LANDSCAPE
- VALUE CHAIN ANALYSIS
- KEY BUYING CRITERIA
- REGULATORY FRAMEWORK
- MARKET BY TYPE
- PRENATAL AND NEWBORN TESTING
- DIAGNOSTIC TESTING
- PREDICTIVE & PRESYMPTOMATIC TESTING
- CARRIER TESTING
- PHARMACOGENOMIC TESTING
- OTHER TYPES
- MARKET BY TECHNOLOGY
- MOLECULAR TESTING
- CYTOGENETIC TESTING
- BIOCHEMICAL TESTING
- MARKET BY APPLICATION
- GENETIC DISEASE DIAGNOSIS
- CANCER DIAGNOSIS
- CARDIOVASCULAR DISEASE DIAGNOSIS
- OTHER APPLICATIONS
- MARKET BY DISEASE
- CANCER
- CYSTIC FIBROSIS
- HUNTINGTON’S DISEASE
- SICKLE CELL ANAEMIA
- DUCHENNE MUSCULAR DYSTROPHY
- ALZHEIMER’S DISEASE
- RARE DISEASES
- THALASSEMIA
- OTHER DISEASES
- GEOGRAPHICAL ANALYSIS
- NORTH AMERICA
- MARKET SIZE & ESTIMATES
- KEY GROWTH ENABLERS
- KEY CHALLENGES
- KEY PLAYERS
- COUNTRY ANALYSIS
- UNITED STATES
- CANADA
- EUROPE
- MARKET SIZE & ESTIMATES
- KEY GROWTH ENABLERS
- KEY CHALLENGES
- KEY PLAYERS
- COUNTRY ANALYSIS
- UNITED KINGDOM
- GERMANY
- FRANCE
- SPAIN
- ITALY
- RUSSIA
- NORDIC COUNTRIES
- REST OF EUROPE
- ASIA-PACIFIC
- MARKET SIZE & ESTIMATE
- KEY GROWTH ENABLERS
- KEY CHALLENGES
- KEY PLAYERS
- COUNTRY ANALYSIS
- CHINA
- JAPAN
- INDIA
- SOUTH KOREA
- INDONESIA
- AUSTRALIA & NEW ZEALAND
- SINGAPORE
- TAIWAN
- REST OF ASIA-PACIFIC
- REST OF WORLD
- MARKET SIZE & ESTIMATES
- KEY GROWTH ENABLERS
- KEY CHALLENGES
- KEY PLAYERS
- REGIONAL ANALYSIS
- LATIN AMERICA
- MIDDLE EAST & AFRICA
- NORTH AMERICA
- COMPETITIVE LANDSCAPE
- KEY STRATEGIC DEVELOPMENTS
- MERGERS & ACQUISITIONS
- PRODUCT LAUNCHES & DEVELOPMENTS
- PARTNERSHIPS & AGREEMENTS
- BUSINESS EXPANSIONS & DIVESTITURES
- COMPANY PROFILES
- 23&ME INC
- ABBOTT LABORATORIES
- BGI GROUP
- BIO-RAD LABORATORIES
- CSL LIMITED
- DECODE GENETICS
- ELITECH GROUP
- EUROFINS SCIENTIFIC
- ILLUMINA INC
- LUMINEX CORPORATION
- MYRIAD GENETICS INC
- PERKINELMER INC
- QIAGEN
- QUEST DIAGNOSTICS INC
- ROCHE DIAGNOSTICS INC
- KEY STRATEGIC DEVELOPMENTS
LIST OF TABLES
TABLE 1: MARKET SNAPSHOT – GENETIC TESTING
TABLE 2: REGULATORY FRAMEWORK
TABLE 3: GLOBAL GENETIC TESTING MARKET, BY TYPE, HISTORICAL YEARS, 2018-2021 (IN $ MILLION)
TABLE 4: GLOBAL GENETIC TESTING MARKET, BY TYPE, FORECAST YEARS, 2022-2030 (IN $ MILLION)
TABLE 5: GLOBAL PRENATAL AND NEWBORN TESTING MARKET, BY REGION, HISTORICAL YEARS, 2018-2021 (IN $ MILLION)
TABLE 6: GLOBAL PRENATAL AND NEWBORN TESTING MARKET, BY REGION, FORECAST YEARS, 2022-2030 (IN $ MILLION)
TABLE 7: GLOBAL DIAGNOSTIC TESTING MARKET, BY REGION, HISTORICAL YEARS, 2018-2021 (IN $ MILLION)
TABLE 8: GLOBAL DIAGNOSTIC TESTING MARKET, BY REGION, FORECAST YEARS, 2022-2030 (IN $ MILLION)
TABLE 9: GLOBAL PREDICTIVE & PRESYMPTOMATIC TESTING MARKET, BY REGION, HISTORICAL YEARS, 2018-2021 (IN $ MILLION)
TABLE 10: GLOBAL PREDICTIVE & PRESYMPTOMATIC TESTING MARKET, BY REGION, FORECAST YEARS, 2022-2030 (IN $ MILLION)
TABLE 11: GLOBAL CARRIER TESTING MARKET, BY REGION, HISTORICAL YEARS, 2018-2021 (IN $ MILLION)
TABLE 12: GLOBAL CARRIER TESTING MARKET, BY REGION, FORECAST YEARS, 2022-2030 (IN $ MILLION)
TABLE 13: GLOBAL PHARMACOGENOMIC TESTING MARKET, BY REGION, HISTORICAL YEARS, 2018-2021 (IN $ MILLION)
TABLE 14: GLOBAL PHARMACOGENOMIC TESTING MARKET, BY REGION, FORECAST YEARS, 2022-2030 (IN $ MILLION)
TABLE 15: GLOBAL OTHER TYPE GENETIC TESTING MARKET, BY REGION, HISTORICAL YEARS, 2018-2021 (IN $ MILLION)
TABLE 16: GLOBAL OTHER TYPE GENETIC TESTING MARKET, BY REGION, FORECAST YEARS, 2022-2030 (IN $ MILLION)
TABLE 17: GLOBAL GENETIC TESTING MARKET, BY TECHNOLOGY, HISTORICAL YEARS, 2018-2021 (IN $ MILLION)
TABLE 18: GLOBAL GENETIC TESTING MARKET, BY TECHNOLOGY, FORECAST YEARS, 2022-2030 (IN $ MILLION)
TABLE 19: GLOBAL MOLECULAR TESTING MARKET, BY REGION, HISTORICAL YEARS, 2018-2021 (IN $ MILLION)
TABLE 20: GLOBAL MOLECULAR TESTING MARKET, BY REGION, FORECAST YEARS, 2022-2030 (IN $ MILLION)
TABLE 21: GLOBAL CYTOGENETIC TESTING MARKET, BY REGION, HISTORICAL YEARS, 2018-2021 (IN $ MILLION)
TABLE 22: GLOBAL CYTOGENETIC TESTING MARKET, BY REGION, FORECAST YEARS, 2022-2030 (IN $ MILLION)
TABLE 23: GLOBAL BIOCHEMICAL TESTING MARKET, BY REGION, HISTORICAL YEARS, 2018-2021 (IN $ MILLION)
TABLE 24: GLOBAL BIOCHEMICAL TESTING MARKET, BY REGION, FORECAST YEARS, 2022-2030 (IN $ MILLION)
TABLE 25: GLOBAL GENETIC TESTING MARKET, BY APPLICATION, HISTORICAL YEARS, 2018-2021 (IN $ MILLION)
TABLE 26: GLOBAL GENETIC TESTING MARKET, BY APPLICATION, FORECAST YEARS, 2022-2030 (IN $ MILLION)
TABLE 27: GLOBAL GENETIC DISEASES DIAGNOSIS MARKET, BY REGION, HISTORICAL YEARS, 2018-2021 (IN $ MILLION)
TABLE 28: GLOBAL GENETIC DISEASES DIAGNOSIS MARKET, BY REGION, FORECAST YEARS, 2022-2030 (IN $ MILLION)
TABLE 29: GLOBAL CANCER DIAGNOSIS MARKET, BY REGION, HISTORICAL YEARS, 2018-2021 (IN $ MILLION)
TABLE 30: GLOBAL CANCER DIAGNOSIS MARKET, BY REGION, FORECAST YEARS, 2022-2030 (IN $ MILLION)
TABLE 31: GLOBAL CARDIOVASCULAR DISEASES DIAGNOSIS MARKET, BY REGION, HISTORICAL YEARS, 2018-2021 (IN $ MILLION)
TABLE 32: GLOBAL CARDIOVASCULAR DISEASES DIAGNOSIS MARKET, BY REGION, FORECAST YEARS, 2022-2030 (IN $ MILLION)
TABLE 33: GLOBAL OTHER APPLICATIONS MARKET, BY REGION, HISTORICAL YEARS, 2018-2021 (IN $ MILLION)
TABLE 34: GLOBAL OTHER APPLICATIONS MARKET, BY REGION, FORECAST YEARS, 2022-2030 (IN $ MILLION)
TABLE 35: GLOBAL GENETIC TESTING MARKET, BY DISEASE, HISTORICAL YEARS, 2018-2021 (IN $ MILLION)
TABLE 36: GLOBAL GENETIC TESTING MARKET, BY DISEASE, FORECAST YEARS, 2022-2030 (IN $ MILLION)
TABLE 37: GLOBAL CANCER MARKET, BY REGION, HISTORICAL YEARS, 2018-2021 (IN $ MILLION)
TABLE 38: GLOBAL CANCER MARKET, BY REGION, FORECAST YEARS, 2022-2030 (IN $ MILLION)
TABLE 39: GLOBAL CYSTIC FIBROSIS MARKET, BY REGION, HISTORICAL YEARS, 2018-2021 (IN $ MILLION)
TABLE 40: GLOBAL CYSTIC FIBROSIS MARKET, BY REGION, FORECAST YEARS, 2022-2030 (IN $ MILLION)
TABLE 41: GLOBAL HUNTINGTON’S DISEASE MARKET, BY REGION, HISTORICAL YEARS, 2018-2021 (IN $ MILLION)
TABLE 42: GLOBAL HUNTINGTON’S DISEASE MARKET, BY REGION, FORECAST YEARS, 2022-2030 (IN $ MILLION)
TABLE 43: GLOBAL SICKLE CELL ANEMIA MARKET, BY REGION, HISTORICAL YEARS, 2018-2021 (IN $ MILLION)
TABLE 44: GLOBAL SICKLE CELL ANEMIA MARKET, BY REGION, FORECAST YEARS, 2022-2030 (IN $ MILLION)
TABLE 45: GLOBAL DUCHENNE MUSCULAR DYSTROPHY MARKET, BY REGION, HISTORICAL YEARS, 2018-2021 (IN $ MILLION)
TABLE 46: GLOBAL DUCHENNE MUSCULAR DYSTROPHY MARKET, BY REGION, FORECAST YEARS, 2022-2030 (IN $ MILLION)
TABLE 47: GLOBAL ALZHEIMER’S DISEASE MARKET, BY REGION, HISTORICAL YEARS, 2018-2021 (IN $ MILLION)
TABLE 48: GLOBAL ALZHEIMER’S DISEASE MARKET, BY REGION, FORECAST YEARS, 2022-2030 (IN $ MILLION)
TABLE 49: GLOBAL RARE DISEASES MARKET, BY REGION, HISTORICAL YEARS, 2018-2021 (IN $ MILLION)
TABLE 50: GLOBAL RARE DISEASES MARKET, BY REGION, FORECAST YEARS, 2022-2030 (IN $ MILLION)
TABLE 51: GLOBAL THALASSEMIA MARKET, BY REGION, HISTORICAL YEARS, 2018-2021 (IN $ MILLION)
TABLE 52: GLOBAL THALASSEMIA MARKET, BY REGION, FORECAST YEARS, 2022-2030 (IN $ MILLION)
TABLE 53: GLOBAL OTHER DISEASES MARKET, BY REGION, HISTORICAL YEARS, 2018-2021 (IN $ MILLION)
TABLE 54: GLOBAL OTHER DISEASES MARKET, BY REGION, FORECAST YEARS, 2022-2030 (IN $ MILLION)
TABLE 55: GLOBAL GENETIC TESTING MARKET, BY GEOGRAPHY, HISTORICAL YEARS, 2018-2021 (IN $ MILLION)
TABLE 56: GLOBAL GENETIC TESTING MARKET, BY GEOGRAPHY, FORECAST YEARS, 2022-2030 (IN $ MILLION)
TABLE 57: NORTH AMERICA GENETIC TESTING MARKET, BY COUNTRY, HISTORICAL YEARS, 2018-2021 (IN $ MILLION)
TABLE 58: NORTH AMERICA GENETIC TESTING MARKET, BY COUNTRY, FORECAST YEARS, 2022-2030 (IN $ MILLION)
TABLE 59: LEADING PLAYERS OPERATING IN NORTH AMERICA GENETIC TESTING MARKET
TABLE 60: EUROPE GENETIC TESTING MARKET, BY COUNTRY, HISTORICAL YEARS, 2018-2021 (IN $ MILLION)
TABLE 61: EUROPE GENETIC TESTING MARKET, BY COUNTRY, FORECAST YEARS, 2022-2030 (IN $ MILLION)
TABLE 62: LEADING PLAYERS OPERATING IN EUROPE GENETIC TESTING MARKET
TABLE 63: ASIA-PACIFIC GENETIC TESTING MARKET, BY COUNTRY, HISTORICAL YEARS, 2018-2021 (IN $ MILLION)
TABLE 64: ASIA-PACIFIC GENETIC TESTING MARKET, BY COUNTRY, FORECAST YEARS, 2022-2030 (IN $ MILLION)
TABLE 65: LEADING PLAYERS OPERATING IN ASIA-PACIFIC GENETIC TESTING MARKET
TABLE 66: REST OF WORLD GENETIC TESTING MARKET, BY REGION, HISTORICAL YEARS, 2018-2021 (IN $ MILLION)
TABLE 67: REST OF WORLD GENETIC TESTING MARKET, BY REGION, FORECAST YEARS, 2022-2030 (IN $ MILLION)
TABLE 68: LEADING PLAYERS OPERATING IN REST OF WORLD GENETIC TESTING MARKET
TABLE 69: LIST OF MERGERS & ACQUISITIONS
TABLE 70: LIST OF PRODUCT LAUNCHES & DEVELOPMENTS
TABLE 71: LIST OF PARTNERSHIPS & AGREEMENTS
TABLE 72: LIST OF BUSINESS EXPANSIONS & DIVESTITURES
LIST OF FIGURES
FIGURE 1: KEY MARKET TRENDS
FIGURE 2: PORTER’S FIVE FORCES ANALYSIS
FIGURE 3: OPPORTUNITY MATRIX
FIGURE 4: VENDOR LANDSCAPE
FIGURE 5: VALUE CHAIN ANALYSIS
FIGURE 6: GLOBAL GENETIC TESTING MARKET, GROWTH POTENTIAL, BY TYPE, IN 2021
FIGURE 7: GLOBAL GENETIC TESTING MARKET, BY PRENATAL AND NEWBORN TESTING GENETIC TESTING, 2022-2030 (IN $ MILLION)
FIGURE 8: GLOBAL GENETIC TESTING MARKET, BY DIAGNOSTIC TESTING, 2022-2030 (IN $ MILLION)
FIGURE 9: GLOBAL CARRIER TESTING MARKET, BY CARRIER TESTING, 2022-2030 (IN $ MILLION)
FIGURE 10: GLOBAL GENETIC TESTING MARKET, BY PHARMACOGENOMIC TESTING, 2022-2030 (IN $ MILLION)
FIGURE 11: GLOBAL GENETIC TESTING MARKET, GROWTH POTENTIAL, BY TECHNOLOGY, IN 2021
FIGURE 12: GLOBAL GENETIC TESTING MARKET, BY MOLECULAR TESTING, 2022-2030 (IN $ MILLION)
FIGURE 13: GLOBAL GENETIC TESTING MARKET, BY CYTOGENETIC TESTING, 2022-2030 (IN $ MILLION)
FIGURE 14: GLOBAL GENETIC TESTING MARKET, BY BIOCHEMICAL TESTING, 2022-2030 (IN $ MILLION)
FIGURE 15: GLOBAL GENETIC TESTING MARKET, GROWTH POTENTIAL, BY APPLICATION, IN 2021
FIGURE 16: GLOBAL GENETIC TESTING MARKET, BY GENETIC DISEASES DIAGNOSIS, 2022-2030 (IN $ MILLION)
FIGURE 17: GLOBAL GENETIC TESTING MARKET, BY CANCER DIAGNOSIS, 2022-2030 (IN $ MILLION)
FIGURE 18: GLOBAL GENETIC TESTING MARKET, BY CARDIOVASCULAR DISEASES DIAGNOSIS, 2022-2030 (IN $ MILLION)
FIGURE 19: GLOBAL GENETIC TESTING MARKET, BY OTHER APPLICATIONS, 2022-2030 (IN $ MILLION)
FIGURE 20: GLOBAL GENETIC TESTING MARKET, GROWTH POTENTIAL, BY DISEASE, IN 2021
FIGURE 21: GLOBAL GENETIC TESTING MARKET, BY CANCER TESTING, 2022-2030 (IN $ MILLION)
FIGURE 22: GLOBAL GENETIC TESTING MARKET, BY CYSTIC FIBROSIS, 2022-2030 (IN $ MILLION)
FIGURE 23: GLOBAL GENETIC TESTING MARKET, BY HUNTINGTON’S DISEASE, 2022-2030 (IN $ MILLION)
FIGURE 24: GLOBAL GENETIC TESTING MARKET, SICKLE CELL ANEMIA, 2022-2030 (IN $ MILLION)
FIGURE 25: GLOBAL GENETIC TESTING MARKET, BY DUCHENNE MUSCULAR DYSTROPHY, 2022-2030 (IN $ MILLION)
FIGURE 26: GLOBAL GENETIC TESTING MARKET, BY ALZHEIMER’S DISEASE TESTING, 2022-2030 (IN $ MILLION)
FIGURE 27: GLOBAL GENETIC TESTING MARKET, BY RARE DISEASES TESTING, 2022-2030 (IN $ MILLION)
FIGURE 28: GLOBAL GENETIC TESTING MARKET, BY THALASSEMIA TESTING, 2022-2030 (IN $ MILLION)
FIGURE 29: GLOBAL GENETIC TESTING MARKET, BY OTHER DISEASES TESTING, 2022-2030 (IN $ MILLION)
FIGURE 30: NORTH AMERICA GENETIC TESTING MARKET, COUNTRY OUTLOOK, 2021 & 2030 (IN %)
FIGURE 31: UNITED STATES GENETIC TESTING MARKET, 2022-2030 (IN $ MILLION)
FIGURE 32: CANADA GENETIC TESTING MARKET, 2022-2030 (IN $ MILLION)
FIGURE 33: EUROPE GENETIC TESTING MARKET, COUNTRY OUTLOOK, 2021 & 2030 (IN %)
FIGURE 33: UNITED KINGDOM GENETIC TESTING MARKET, 2022-2030 (IN $ MILLION)
FIGURE 34: GERMANY GENETIC TESTING MARKET, 2022-2030 (IN $ MILLION)
FIGURE 35: SPAIN GENETIC TESTING MARKET, 2022-2030 (IN $ MILLION)
FIGURE 36: ITALY GENETIC TESTING MARKET, 2022-2030 (IN $ MILLION)
FIGURE 37: RUSSIA GENETIC TESTING MARKET, 2022-2030 (IN $ MILLION)
FIGURE 38: NORDIC COUNTRIES GENETIC TESTING MARKET, 2022-2030 (IN $ MILLION)
FIGURE 39: REST OF EUROPE GENETIC TESTING MARKET, 2022-2030 (IN $ MILLION)
FIGURE 40: ASIA-PACIFIC GENETIC TESTING MARKET, COUNTRY OUTLOOK, 2021 & 2030 (IN %)
FIGURE 41: CHINA GENETIC TESTING MARKET, 2022-2030 (IN $ MILLION)
FIGURE 42: JAPAN GENETIC TESTING MARKET, 2022-2030 (IN $ MILLION)
FIGURE 43: INDIA GENETIC TESTING MARKET, 2022-2030 (IN $ MILLION)
FIGURE 44: SOUTH KOREA GENETIC TESTING MARKET, 2022-2030 (IN $ MILLION)
FIGURE 45: INDONESIA GENETIC TESTING MARKET, 2022-2030 (IN $ MILLION)
FIGURE 46: AUSTRALIA & NEW ZEALAND GENETIC TESTING MARKET, 2022-2030 (IN $ MILLION)
FIGURE 45: SINGAPORE GENETIC TESTING MARKET, 2022-2030 (IN $ MILLION)
FIGURE 45: TAIWAN GENETIC TESTING MARKET, 2022-2030 (IN $ MILLION)
FIGURE 47: REST OF ASIA-PACIFIC GENETIC TESTING MARKET, 2022-2030 (IN $ MILLION)
FIGURE 48: REST OF WORLD GENETIC TESTING MARKET, REGIONAL OUTLOOK, 2021 & 2030 (IN %)
FIGURE 49: LATIN AMERICA GENETIC TESTING MARKET, 2022-2030 (IN $ MILLION)
FIGURE 50: MIDDLE EAST & AFRICA GENETIC TESTING MARKET, 2022-2030 (IN $ MILLION)
